Iqvia Inc.
USPTO PatentsView assignee record - 91 granted patents across 13 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data).
The verdict
According to USPTO PatentsView, Iqvia ranks #3,970 of 49,997 tracked US assignees by granted-patent volume, with 91 patents across 13 technology areas.
- #3,970
- of 49,997 US assignees by volume
- Top 11%
- by Innovation Score (51.5/100)
- 20.5
- avg claims per patent
- +527%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R3970 · US Corporation #3,970 · 91 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 91 grants
- TOP-DECILE #3,970/49,997
- PHOTO-FINISH Evalve
- CPC-FOCUS G16H · 13 areas
- INNOV-PAR 51.5/100
- CLAIMS-DENSE 20.5 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +527% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Evalve, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Iqvia’s 51.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Iqvia
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Aviat U S · near
Aviat U S · near
52 score
- Global Technology · near
Global Technology · near
52 score
- Institute OF… · near
Institute OF… · near
52 score
- Iqvia · this assignee
Iqvia · this assignee
52 score
- US Conec · near
US Conec · near
52 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Iqvia's Innovation Score is 51.5/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Iqvia?
Each dot is one of Iqvia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Iqvia’s own 20.5 claims/patent is ABOVE the 16.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Iqvia's grants concentrate
Iqvia Inc. is a focused PatentsView assignee: 13 CPC subclasses with 64.8% of grants classified under G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data). Peak complete grant year is 2024 (23 grants) versus a trough of 1 in 2018. By volume, Iqvia sits between Evalve, Inc. and Kistler Holding AG.
Iqvia's three-year grant acceleration
From 2019–2021 to 2022–2024, Iqvia Inc. moved from 30 to 49 grants (1.63x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Iqvia's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Evalve
Evalve, Inc.
91 patents
- Galderma Holding
Galderma Holding SA
91 patents
- Hover
Hover Inc.
91 patents
- Idexx Laboratories
Idexx Laboratories Inc.
91 patents
- JGC Catalysts and…
JGC Catalysts and Chemicals Ltd.
91 patents
- Joyetech Europe H…
Joyetech Europe Holding GmbH
91 patents
- Kofax
Kofax, Inc.
91 patents
- Kistler Holding
Kistler Holding AG
91 patents
- Iqvia ◀
Iqvia Inc.
91 patents
What this shows Iqvia holds 91 patents at rank #3,970, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Iqvia
By rank, the assignees closest to #3,970 in granted patent volume.
- Evalve, Inc. #3,966 · 91 patents
- Galderma Holding SA #3,967 · 91 patents
- Hover Inc. #3,968 · 91 patents
- Idexx Laboratories Inc. #3,969 · 91 patents
- JGC Catalysts and Chemicals Ltd. #3,971 · 91 patents
- Joyetech Europe Holding GmbH #3,972 · 91 patents
- Kofax, Inc. #3,973 · 91 patents
- Kistler Holding AG #3,974 · 91 patents
Leaders in G16H (Healthcare Informatics)
Other assignees with the most granted patents in Iqvia's primary technology class.
- Koniniklijke Philips N.V. 1,161 in class
- International Business Machines Corporation 1,121 in class
- Cerner Innovation, Inc. 500 in class
- Siemens Healthcare Limited 498 in class
- Fujifilm Corporation 378 in class
- Dexcom, Inc. 333 in class
- Cilag GmbH International 319 in class
- Medtronic, Inc. 312 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Iqvia, neither rank-band nor same-CPC leaders (those blocks stay above). In G16H (Healthcare Informatics), Iqvia ranks #85 of 3,149 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (52 here).
Similar claim depth
Nearest assignees by average claims per patent (20.5 here).
Iqvia's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
52 Top 11% higher than 89% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 1.1% |
| 2019 | 10 | 11.0% |
| 2020 | 12 | 13.2% |
| 2021 | 8 | 8.8% |
| 2022 | 11 | 12.1% |
| 2023 | 15 | 16.5% |
| 2024 | 23 | 25.3% |
| 2025partial year | 11 | 12.1% |
Which technologies does Iqvia Inc. patent most?
Top 13 of 13 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Iqvia Inc.'s patent record in context - here's where to go next.
- Iqvia Inc.'s lead technology class is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data), 64.8% of its portfolio - see every assignee active in that class. Explore G16H
- Ranked #3,970 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Iqvia Inc. against Evalve, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 51.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.